Entrada Therapeutics, Inc. (TRDA)
$7.33-3.17%Close
BUYRECOVERY · day 18
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $285M
- Avg volume
- 413.5K
- Beta
- -0.26
- P/E (TTM)
- -1.85
- Short % float
- 9.65%
- Days to cover
- 4.3
- SI change
- -3.9%
- 1W
- +0.14%
- 1M
- +25.30%
- 3M
- +11.74%
- YTD
- -27.06%
- vs SPY 1W
- +1.33%
- vs SPY 1M
- +21.98%
- vs SPY 3M
- +9.35%
- vs SPY YTD
- -38.82%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- PARKBUYPark Dental Partners, Inc. Common StockQ 80$20.74+0.63%
- PBLSBUYParabilis Medicines, Inc.Q 72$38.43-2.36%
- CVMBUYCEL-SCI CorporationCRISISQ 4$1.38-2.82%
- ALMSSELLAlumis Inc. Common StockCRISISQ 32$23.03-4.72%
- NAMSSELLNewAmsterdam Pharma Company N.V.RECOVERYQ 29$26.85-3.66%
- OVIDBUYOvid Therapeutics Inc.RECOVERYQ -8$2.82+0.71%
- VRAXSELLVirax Biolabs Group LimitedRECOVERYQ -25$3.00-5.96%
- RVPBUYRetractable Technologies, Inc.RECOVERYQ 7$0.73+0.00%
- LFWDSELLLifeward Ltd.RECOVERYQ -16$7.29-0.41%
- TWSTBUYTwist Bioscience CorporationBULLQ 30$140.80-3.29%
- NEOGBUYNeogen CorporationBULLQ 16$11.60-2.93%
- MAZESELLMaze Therapeutics, Inc.RECOVERYQ 40$29.60+0.58%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 15
- GROWTH
- 2
- GARP
- 3
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC-34.6%
REV YoY-
ROE-57.6%
EPS YoY-
ROA-55.5%
GROSS-755
OP-3767
NET-3538
[VALUATION]
P/E TTM-1.85
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B1.33
P/FCF-
EV/EBITDA-1.42
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E20.80
ALTMAN Z-
CURR RATIO10.89
ND/EBITDA-
BETA-0.26
